Fumarate Hydratase Deficiency in Renal Cancer Induces Glycolytic Addiction and Hypoxia-Inducible Transcription Factor 1α Stabilization by Glucose-Dependent Generation of Reactive Oxygen Species

On the origin of cancer cells

Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · see citing works

Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O ₂ -Regulated Prolyl Hydroxylation

Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · see citing works

HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O ₂ Sensing

Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · see citing works

HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia

Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · see citing works

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333 · see citing works

A conserved family of prolyl-4-hydroxylases that modify HIF

Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549 · see citing works

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase

Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · see citing works

Mutations of the VHL tumour suppressor gene in renal carcinoma

Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730 · see citing works

Hypoxia, HIF1 and glucose metabolism in the solid tumour

Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707 · see citing works

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635 · see citing works

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · see citing works

HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability

Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958 · see citing works

Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations

Pollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi227 · Cited by 865 · see citing works

High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers.

Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E. K., & Mueller‐Klieser, W. (2000) · PubMed · Cited by 817 · see citing works

Inherited susceptibility to uterine leiomyomas and renal cell cancer

Launonen, V., Vierimaa, O., Kiuru, M., Isola, J., Roth, S., Pukkala, E., Sistonen, P., Herva, R., & Aaltonen, L. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051633798 · Cited by 669 · see citing works

Mitochondrial tumour suppressors: a genetic and biochemical update

Gottlieb, E., & Tomlinson, I. P. M. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1737 · Cited by 617 · see citing works

HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo

Gao, P., Zhang, H., Dinavahi, R., Li, F., Xiang, Y., Raman, V., Bhujwalla, Z. M., Felsher, D. W., Cheng, L., Pevsner, J., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.004 · Cited by 523 · see citing works

Inhibition of Hypoxia-inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates

Koivunen, P., Hirsilä, M., Remes, A. M., Hassinen, I. E., Kivirikko, K. I., & Myllyharju, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610415200 · Cited by 521 · see citing works

Hypoxia-inducible factors: central regulators of the tumor phenotype

Gordan, J. D., & Simon, M. C. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.006 · Cited by 450 · see citing works

Protein Kinase C–Dependent Increase in Reactive Oxygen Species (ROS) Production in Vascular Tissues of Diabetes: Role of Vascular NAD(P)H Oxidase

Inoguchi, T., Sonta, T., Tsubouchi, H., Etoh, T., Kakimoto, M., Sonoda, N., Sato, N., Sekiguchi, N., Kobayashi, K., Sumimoto, H., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077407.90309.65 · Cited by 435 · see citing works

Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis

Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S., & Schumacker, P. T. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01338-07 · Cited by 427 · see citing works

Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1

Lu, H., Dalgard, C. L., Mohyeldin, A., McFate, T., Tait, A. S., & Verma, A. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508718200 · Cited by 400 · see citing works

Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose

Ha, H., & Lee, H. B. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07704.x · Cited by 311 · see citing works

Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.

Wiesener, M. S., Münchenhagen, P., Berger, I., Morgan, N. V., Roigas, J., Schwiertz, A., Jürgensen, J. S., Gruber, G., Maxwell, P. H., Löning, S. A., et al. (2001) · PubMed · Cited by 308 · see citing works

Hereditary Leiomyomatosis and Renal Cell Cancer: A Syndrome Associated With an Aggressive Form of Inherited Renal Cancer

Grubb, R. L., FRANKS, M. E., Toro, J. R., Middelton, L. A., Choyke, L. T., Fowler, S. E., Torres-Cabala, C. A., Glenn, G. M., Choyke, P. L., Merino, M. J., et al. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.01.155 · Cited by 282 · see citing works

LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer

Xie, H., Valera, V., Merino, M. J., Amato, A. M., Signoretti, S., Linehan, W. M., Sukhatme, V. P., & Seth, P. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1049 · Cited by 232 · see citing works

Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer

Koukourakis, M. I., Giatromanolaki, A. N., Simopoulos, C., Polychronidis, A., & Sivridis, E. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-2343-7 · Cited by 227 · see citing works

The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing

Kaelin, W. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.165 · Cited by 213 · see citing works

Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells

Wang, X., Perez, E., Liu, R., Yan, L., Mallet, R. T., & Yang, S. (2006) · Brain Research · doi:10.1016/j.brainres.2006.11.032 · Cited by 203 · see citing works

A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death

Wood, T. E., Dalili, S., Simpson, C. D., Hurren, R., Mao, X., Suárez, F., Gronda, M., Eberhard, Y., Minden, M. D., Bilan, P. J., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0569 · Cited by 197 · see citing works

Lactate stimulates endothelial cell migration

Beckert, S., Farrahi, F., Aslam, R. S., Scheuenstuhl, H., Königsrainer, A., Hussain, M., & Hunt, T. K. (2006) · Wound Repair and Regeneration · doi:10.1111/j.1743-6109.2006.00127.x · Cited by 187 · see citing works

Targeted Inactivation of Fh1 Causes Proliferative Renal Cyst Development and Activation of the Hypoxia Pathway

Pollard, P. J., Spencer‐Dene, B., Shukla, D., Howarth, K. M., Nye, E. L., El-Bahrawy, M. A., Deheragoda, M. G., Kolatsi‐Joannou, M., McDonald, S. A. C., Martin, A., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.005 · Cited by 177 · see citing works

Endothelial cell response to lactate: Implication of PAR modification of VEGF

Kumar, V. B. S., Viji, R. I., Kiran, M. S., & Sudhakaran, P. R. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20955 · Cited by 143 · see citing works

PKC-δ-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase

Talior, I., Tennenbaum, T., Kuroki, T., & Eldar-Finkelman, H. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00378.2004 · Cited by 120 · see citing works

NAD(P)H Oxidases Regulate HIF-2α Protein Expression

Block, K. L., Gorin, Y. C., Hoover, P., Williams, P., Chełmicki, T., Clark, R. A., Yoneda, T., & Abboud, H. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611569200 · Cited by 117 · see citing works

Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome

Pollard, P., Wortham, N., Barclay, E., Alam, A., Elia, G., Manek, S., Poulsom, R., & Tomlinson, I. (2005) · The Journal of Pathology · doi:10.1002/path.1686 · Cited by 100 · see citing works

A computational model of intracellular oxygen sensing by hypoxia-inducible factor HIF1α

Qutub, A. A., & Popel, A. S. (2006) · Journal of Cell Science · doi:10.1242/jcs.03087 · Cited by 87 · see citing works

High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells

Haller, H. G., Baur, E., Quass, P., Lindschau, C., Distler, A., & Luft, F. C. (1995) · Kidney International · doi:10.1038/ki.1995.152 · Cited by 74 · see citing works

HIF and fumarate hydratase in renal cancer

Sudarshan, S., Linehan, W. M., & Neckers, L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603547 · Cited by 70 · see citing works

Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer

Pithukpakorn, M., Wei, M.-H., Toure, O., Steinbach, P. J., Glenn, G. M., Zbar, B., Linehan, W. M., & Toro, J. R. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.041087 · Cited by 53 · see citing works

NAD(P)H oxidase participates in the signaling events in high glucose-induced proliferation of vascular smooth muscle cells

Lee, H. S., Son, S. M., Kim, Y.-K., Hong, K. W., & Kim, C. D. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00186-3 · Cited by 44 · see citing works

Cytoprotection by pyruvate through an anti-oxidative mechanism in cultured rat calvarial osteoblasts.

Moriguchi, N., Hinoi, E., Tsuchihashi, Y., Fujimori, S., Iemata, M., Takarada, T., & Yoneda, Y. (2006) · PubMed · doi:10.14670/hh-21.969 · Cited by 23 · see citing works

Modeling tumor predisposingFHmutations in yeast: Effects on fumarase activity, growth phenotype and gene expression profile

Kokko, A., Ylisaukko‐oja, S. K., Kiuru, M. H., Takatalo, M. S., Salmikangas, P., Tuimala, J., Arango, D., Karhu, A., Aaltonen, L. A., & Jäntti, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21423 · Cited by 9 · see citing works

Hypoxia-inducible factors and the response to hypoxic stress

Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380 · see citing works

Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?

Sabharwal, S. S., & Schumacker, P. T. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3803 · Cited by 1,643 · see citing works

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

The Cancer Genome Atlas Research Network (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505917 · Cited by 1,336 · see citing works

NRF2 and cancer: the good, the bad and the importance of context

Sporn, M. B., & Liby, K. T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3278 · Cited by 1,067 · see citing works

Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?

DeBerardinis, R. J., & Thompson, C. B. (2012) · Cell · doi:10.1016/j.cell.2012.02.032 · Cited by 858 · see citing works

Mitochondrial reactive oxygen species and cancer

Sullivan, L. B., & Chandel, N. S. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-17 · Cited by 799 · see citing works

The genetic basis of kidney cancer: a metabolic disease

Linehan, W. M., Srinivasan, R., & Schmidt, L. S. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.47 · Cited by 743 · see citing works

Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy

Yang, Y., Karakhanova, S., Hartwig, W., D’Haese, J. G., Philippov, P. P., Werner, J., & Bazhin, A. V. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25349 · Cited by 671 · see citing works

Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase

Frezza, C., Zheng, L., Folger, O., Rajagopalan, K. N., MacKenzie, E. D., Jerby, L., Micaroni, M., Chaneton, B., Adam, J., Hedley, A., et al. (2011) · Nature · doi:10.1038/nature10363 · Cited by 503 · see citing works

Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity

Dahia, P. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3648 · Cited by 545 · see citing works

The complexity of the Nrf2 pathway: beyond the antioxidant response

Huang, Y. S., Li, W., Su, Z., & Kong, A. T. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.001 · Cited by 449 · see citing works

Altered metabolite levels in cancer: implications for tumour biology and cancer therapy

Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.85 · Cited by 406 · see citing works

Aerobic glycolysis tunes YAP/TAZ transcriptional activity

Enzo, E., Santinon, G., Pocaterra, A., Aragona, M., Bresolin, S., Forcato, M., Grifoni, D., Pession, A., Zanconato, F., Guzzo, G., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490379 · Cited by 414 · see citing works

Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis

Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00862-0 · Cited by 414 · see citing works

An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma

Ooi, A., Wong, J.-C., Petillo, D., Roossien, D., Perrier-Trudova, V., Whitten, D., Min, B. W. H., Tan, M.-H., Zhang, Z., Yang, X. J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.024 · Cited by 401 · see citing works

Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors

Andrejeva, G., & Rathmell, J. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.004 · Cited by 368 · see citing works

The Metabolic Basis of Kidney Cancer

Linehan, W. M., Schmidt, L. S., Crooks, D. R., Wei, D., Srinivasan, R., Lang, M., & Ricketts, C. J. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1354 · Cited by 336 · see citing works

Role of mitochondrial dysfunction in cancer progression

Hsu, C., Tseng, L., & Lee, H. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216641787 · Cited by 306 · see citing works

The Proto-oncometabolite Fumarate Binds Glutathione to Amplify ROS-Dependent Signaling

Sullivan, L. B., Martinez-Garcia, E., Nguyen, H., Mullen, A. R., Dufour, E., Sudarshan, S., Licht, J. D., Deberardinis, R. J., & Chandel, N. S. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.003 · Cited by 304 · see citing works

Aiding and abetting roles of NOX oxidases in cellular transformation

Block, K. L., & Gorin, Y. C. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3339 · Cited by 301 · see citing works

Fumarate induces redox-dependent senescence by modifying glutathione metabolism

Zheng, L., Cardaci, S., Jerby, L., MacKenzie, E. D., Sciacovelli, M., Johnson, T. I., Gaude, E., King, A., Leach, J. D. G., Edrada-Ebel, R., et al. (2015) · Nature Communications · doi:10.1038/ncomms7001 · Cited by 281 · see citing works

Reactive oxygen species-dependent signaling regulates cancer

Weinberg, F. D., & Chandel, N. S. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0099-y · Cited by 276 · see citing works

Fumarate Hydratase–deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome

Trpkov, K., Hes, O., Agaimy, A., Bonert, M., Martínek, P., Magi‐Galluzzi, C., Kristiansen, G., Lüders, C., Nesi, G., Compérat, É., et al. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000617 · Cited by 259 · see citing works

Molecular Pathways: Fumarate Hydratase -Deficient Kidney Cancer—Targeting the Warburg Effect in Cancer

Linehan, W. M., & Rouault, T. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0304 · Cited by 223 · see citing works

The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels

Tong, W.-H., Sourbier, C., Kovtunovych, G., Jeong, S. Y., Vira, M., Ghosh, M., Romero, V. V., Sougrat, R., Vaulont, S., Viollet, B., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.07.018 · Cited by 212 · see citing works

Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease

You, Y.-H., Quach, T., Saito, R., Pham, J., & Sharma, K. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015030302 · Cited by 191 · see citing works

The emerging role of fumarate as an oncometabolite

Yang, M., Soga, T., Pollard, P. J., & Adam, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00085 · Cited by 189 · see citing works

Molecular Diagnosis and Therapy of Kidney Cancer

Linehan, W. M., Bratslavsky, G., Pinto, P. A., Schmidt, L. S., Neckers, L., Bottaro, D. P., & Srinivasan, R. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.042808.171650 · Cited by 166 · see citing works

TCA Cycle Defects and Cancer: When Metabolism Tunes Redox State

Cardaci, S., & Ciriolo, M. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/161837 · Cited by 162 · see citing works

State of the Science: An Update on Renal Cell Carcinoma

Jonasch, E. W., Futreal, P. A., Davis, I. J., Bailey, S. T., Kim, W. Y., Brugarolas, J., Giaccia, A. J., Kurban, G., Pause, A., Frydman, J., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0117 · Cited by 161 · see citing works

Cancer and Altered Metabolism: Potential Importance of Hypoxia-Inducible Factor and 2-Oxoglutarate-Dependent Dioxygenases

Kaelin, W. G. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010975 · Cited by 161 · see citing works

Dimethyl fumarate, a two‐edged drug: Current status and future directions

Saidu, N. E. B., Kavian, N., Leroy, K., Jacob, C., Nicco, C., Batteux, F., & Alexandre, J. (2019) · Medicinal Research Reviews · doi:10.1002/med.21567 · Cited by 160 · see citing works

Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics

Lehtonen, H. J. (2011) · Familial Cancer · doi:10.1007/s10689-011-9428-z · Cited by 154 · see citing works

Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by “antioxidant” metal chelators: From ferroptosis to stroke

Speer, R. E., Karuppagounder, S. S., Basso, M., Sleiman, S. F., Kumar, A., Brand, D., Smirnova, N., Gazaryan, I. G., Khim, S. J., & Ratan, R. R. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.026 · Cited by 155 · see citing works

Targeting cancer metabolism

Teicher, B. A., Linehan, W. M., & Helman, L. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2587 · Cited by 152 · see citing works

Epidemiology and Prevention of Renal Cell Carcinoma

Makino, T., Kadomoto, S., Izumi, K., & Mizokami, A. (2022) · Cancers · doi:10.3390/cancers14164059 · Cited by 151 · see citing works

Inborn and acquired metabolic defects in cancer

Frezza, C., Pollard, P. J., & Gottlieb, E. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0728-4 · Cited by 146 · see citing works

Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma

Gardie, B., Remenieras, A., Kattygnarath, D., Bombled, J., Lefèvre, S.-H., Perrier-Trudova, V., Rustin, P., Barrois, M., Slama, A., Avril, M., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.085068 · Cited by 143 · see citing works

UOK 262 cell line, fumarate hydratase deficient (FH−/FH−) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer

Yang, Y., Valera, V., Padilla‐Nash, H. M., Sourbier, C., Vocke, C. D., Vira, M. A., Abu-Asab, M. S., Bratslavsky, G., Tsokos, M., Merino, M. J., et al. (2009) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2009.08.018 · Cited by 139 · see citing works

Morphologic and Molecular Characteristics of Uterine Leiomyomas in Hereditary Leiomyomatosis and Renal Cancer (HLRCC) Syndrome

Sanz‐Ortega, J., Vocke, C. D., Stratton, P., Linehan, W. M., & Merino, M. J. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31825ec16f · Cited by 132 · see citing works

Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight

Al‐Khallaf, H. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0165-3 · Cited by 127 · see citing works

HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice

Nayak, B. K., Shanmugasundaram, K., Friedrichs, W. E., Cavaglierii, R. C., Patel, M., Barnes, J. L., & Block, K. L. (2016) · Diabetes · doi:10.2337/db15-0519 · Cited by 124 · see citing works

A chemoproteomic portrait of the oncometabolite fumarate

Kulkarni, R. A., Bak, D. W., Wei, D., Bergholtz, S. E., Briney, C. A., Shrimp, J. H., Alpsoy, A., Thorpe, A. L., Bavari, A. E., Crooks, D. R., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-018-0217-y · Cited by 121 · see citing works

Genetic alterations in Krebs cycle and its impact on cancer pathogenesis

Sajnani, K., Islam, F., Smith, R. A., Gopalan, V., & Lam, A. K.-Y. (2017) · Biochimie · doi:10.1016/j.biochi.2017.02.008 · Cited by 116 · see citing works

Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights

Carlo, M. I., Hakimi, A. A., Stewart, G. D., Bratslavsky, G., Brugarolas, J., Chen, Y., Linehan, W. M., Maher, E. R., Merino, M. J., Offit, K., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.06.015 · Cited by 118 · see citing works

Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism

O′Flaherty, L., Adam, J., Heather, L. C., Zhdanov, A. V., Chung, Y., Miranda, M. X., Croft, J., Olpin, S. E., Clarke, K. J., Pugh, C. W., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq305 · Cited by 108 · see citing works

Targeting ABL1-Mediated Oxidative Stress Adaptation in Fumarate Hydratase-Deficient Cancer

Sourbier, C., Ricketts, C. J., Matsumoto, S., Crooks, D. R., Liao, P., Mannes, P. Z., Yang, Y., Wei, M.-H., Srivastava, G. K., Ghosh, S., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.005 · Cited by 108 · see citing works

New Strategies in Renal Cell Carcinoma: Targeting the Genetic and Metabolic Basis of Disease

Srinivasan, R., Ricketts, C. J., Sourbier, C., & Linehan, W. M. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2993 · Cited by 108 · see citing works

Integrated Molecular Characterization of Fumarate Hydratase–deficient Renal Cell Carcinoma

Sun, G., Zhang, X., Liang, J., Pan, X., Zhu, S., Liu, Z., Armstrong, C. M., Chen, J., Lin, W., Liao, B., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3788 · Cited by 102 · see citing works

Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma

Yang, Y., Lane, A. N., Ricketts, C. J., Sourbier, C., Wei, M.-H., Shuch, B. M., Pike, L. S., Wu, M., Rouault, T. A., Boros, L. G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072179 · Cited by 103 · see citing works

Cancer cell metabolism and the modulating effects of nitric oxide

Chang, C.-F., Diers, A. R., & Hogg, N. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.11.012 · Cited by 101 · see citing works

A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia

Adam, J., Yang, M., Bauerschmidt, C., Kitagawa, M., O’Flaherty, L., Maheswaran, P., Özkan, G., Sahgal, N., Baban, D., Kato, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.006 · Cited by 97 · see citing works

Metabolic alterations in renal cell carcinoma

Massari, F., Ciccarese, C., Santoni, M., Brunelli, M., Piva, F., Modena, A., Bimbatti, D., Fantinel, E., Santini, D., Liang Cheng, C., et al. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.07.002 · Cited by 97 · see citing works

Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the W arburg effect

Cottrill, K. A., & Chan, S. Y. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12104 · Cited by 94 · see citing works

The Relationship of Thioredoxin-1 and Cisplatin Resistance: Its Impact on ROS and Oxidative Metabolism in Lung Cancer Cells

Wangpaichitr, M., Sullivan, E. J., Theodoropoulos, G., Wu, C., You, M., Feun, L. G., Lampidis, T. J., Kuo, M. T., & Savaraj, N. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0599 · Cited by 94 · see citing works

Aerobic glycolysis: a novel target in kidney cancer

Shuch, B. M., Linehan, W. M., & Srinivasan, R. (2013) · Expert Review of Anticancer Therapy · doi:10.1586/era.13.57 · Cited by 92 · see citing works

Rare insights into cancer biology

Adam, J., Yang, M., Soga, T., & Pollard, P. J. (2013) · Oncogene · doi:10.1038/onc.2013.222 · Cited by 88 · see citing works

HIF-1α as a central mediator of cellular resistance to intracellular pathogens

Knight, M., & Stanley, S. A. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.05.005 · Cited by 86 · see citing works

Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research

Ooi, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.016 · Cited by 83 · see citing works

Emerging Metabolic Targets in Cancer Therapy

Zhao, Y. (2010) · Frontiers in bioscience · doi:10.2741/3826 · Cited by 82 · see citing works

Metabolomic Analysis Reveals Increased Aerobic Glycolysis and Amino Acid Deficit in a Cellular Model of Amyotrophic Lateral Sclerosis

Valbuena, G. N., Rizzardini, M., Cimini, S., Siskos, A., Bendotti, C., Cantoni, L., & Keun, H. C. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9165-7 · Cited by 81 · see citing works

Adrenal Nodular Hyperplasia in Hereditary Leiomyomatosis and Renal Cell Cancer

Shuch, B. M., Ricketts, C. J., Vocke, C. D., Valera, V., Chen, C. C., Gautam, R., Gupta, G. N., Gómez-Macias, G. S., Merino, M. J., Bratslavsky, G., et al. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.07.139 · Cited by 79 · see citing works

Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome)

Buelow, B., Cohen, J. N., Nagymányoki, Z., Frizzell, N., Joseph, N. M., McCalmont, T. H., & Garg, K. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000626 · Cited by 79 · see citing works

Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma.

Ge, X., Li, M.-D., Yin, J.-X., Shi, Z.-M., Fu, Y., Zhao, N.-W., Chen, H., Meng, L., Li, X., Hu, Z., et al. (2022) · Molecules and Cells · doi:10.1016/j.molcel.2022.01.029 · Cited by 67 · see citing works

Metabolism of Kidney Cancer: From the Lab to Clinical Practice

Sudarshan, S., Karam, J. A., Brugarolas, J., Thompson, R. H., Uzzo, R. G., Rini, B. I., Margulis, V., Patard, J., Escudier, B. J., & Linehan, W. M. (2012) · European Urology · doi:10.1016/j.eururo.2012.09.054 · Cited by 79 · see citing works

Metabolic Alterations in Cancer and Their Potential as Therapeutic Targets

Weyandt, J. D., Thompson, C. B., Giaccia, A. J., & Rathmell, W. K. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175561 · Cited by 75 · see citing works

Inter‐connection between mitochondria and HIFs

Tormos, K. V., & Chandel, N. S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01031.x · Cited by 75 · see citing works

Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanoma

Luo, S., Li, Y., Ma, R., Liu, J., Xu, P., Zhang, H.-B., Tang, K., Ma, J., Liu, N., Zhang, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2016.520 · Cited by 74 · see citing works

Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer

Wu, C., Wyatt, A. W., Lapuk, A. V., McPherson, A., McConeghy, B. J., Bell, R. H., Anderson, S. A., Haegert, A. M., Brahmbhatt, S., Shukin, R. J., et al. (2012) · The Journal of Pathology · doi:10.1002/path.3987 · Cited by 73 · see citing works

Absence of the Birt–Hogg–Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility

Preston, R. S., Philp, A., Claessens, T., Gijezen, L., Dydensborg, A. B., Dunlop, E. A., Harper, K., Brinkhuizen, T., Menko, F. H., Davies, D. M., et al. (2010) · Oncogene · doi:10.1038/onc.2010.497 · Cited by 72 · see citing works

Expression Profiling in Progressive Stages of Fumarate-Hydratase Deficiency: The Contribution of Metabolic Changes to Tumorigenesis

Ashrafian, H., O′Flaherty, L., Adam, J., Steeples, V., Chung, Y., East, P., Vanharanta, S., Lehtonen, H. J., Nye, E. L., Hatipoglu, E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1949 · Cited by 72 · see citing works

H19X-encoded miR-424(322)/-503 cluster: emerging roles in cell differentiation, proliferation, plasticity and metabolism

Wang, F., Liang, R., Tandon, N., Matthews, E. R., Shrestha, S., Yang, J., Soibam, B., Yang, J., & Liu, Y. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2971-0 · Cited by 71 · see citing works

Metabolic Pathways in Kidney Cancer: Current Therapies and Future Directions

Rathmell, W. K., Rathmell, J. C., & Linehan, W. M. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.2309 · Cited by 64 · see citing works

Precision medicine from the renal cancer genome

Riazalhosseini, Y., & Lathrop, M. G. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.133 · Cited by 69 · see citing works

The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy

Hoerner, C. R., Chen, V. J., & Fan, A. C. (2019) · Kidney Cancer · doi:10.3233/kca-180043 · Cited by 68 · see citing works

Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis

Barger, J. F., & Plas, D. R. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0106 · Cited by 65 · see citing works

SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling

Kaelin, W. G. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.013 · Cited by 67 · see citing works

GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway

Li, J., Wang, Q., Yang, Y., Lei, C., Yang, F., Liang, L., Chen, C., Xia, J. L., Wang, K., & Tang, N. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1459-6 · Cited by 66 · see citing works

A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer

Yang, Y., Valera, V., Sourbier, C., Vocke, C. D., Wei, M., Pike, L., Huang, Y. K., Merino, M. A., Bratslavsky, G., Wu, M., et al. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.05.001 · Cited by 65 · see citing works

New Insights into the Biology of Renal Cell Carcinoma

Li, L., & Kaelin, W. G. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2011.04.004 · Cited by 62 · see citing works

Cancer may be a pathway to cell survival under persistent hypoxia and elevated ROS: A model for solid‐cancer initiation and early development

Zhang, C., Cao, S., Toole, B. P., & Xu, Y. (2014) · International Journal of Cancer · doi:10.1002/ijc.28975 · Cited by 63 · see citing works

The Oncometabolite Fumarate Promotes Pseudohypoxia Through Noncanonical Activation of NF-κB Signaling

Shanmugasundaram, K., Nayak, B., Shim, E., Livi, C. B., Block, K. L., & Sudarshan, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568162 · Cited by 60 · see citing works

Decreased expression of the mitochondrial metabolic enzyme aconitase (ACO2) is associated with poor prognosis in gastric cancer

Wang, P., Mai, C., Wei, Y.-L., Zhao, J.-J., Hu, Y.-M., Zeng, Z.-L., Yang, J., Lu, W.-H., Xu, R., & Huang, P. (2013) · Medical Oncology · doi:10.1007/s12032-013-0552-5 · Cited by 60 · see citing works

LncRNA‐TP53TG1 Participated in the Stress Response Under Glucose Deprivation in Glioma

Chen, X., Gao, Y., Li, D., Cao, Y., & Hao, B. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26175 · Cited by 59 · see citing works

Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation

Sun, Y., Bandi, M. L., Lofton, T. E., Smith, M. G., Bristow, C. A., Carugo, A., Rogers, N. E., Leonard, P. G., Chang, Q., Mullinax, R. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.043 · Cited by 59 · see citing works

RHOBTB3 promotes proteasomal degradation of HIFα through facilitating hydroxylation and suppresses the Warburg effect

Zhang, C., Liu, Q., Li, M., Lin, S., Peng, Y., Wu, D., Li, T. Y., Fu, Q., Jia, W., Wang, X., et al. (2015) · Cell Research · doi:10.1038/cr.2015.90 · Cited by 55 · see citing works

Mitochondrial proteomic analysis reveals deficiencies in oxygen utilization in medullary thick ascending limb of Henle in the Dahl salt-sensitive rat

Zheleznova, N. N., Yang, C., Ryan, R. P., Halligan, B. D., Liang, M., Greene, A. S., & Cowley, A. W. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00060.2012 · Cited by 54 · see citing works

The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy

Wu, J., Liu, N., Chen, J., Tao, Q., Li, Q., Li, J., Chen, X., & Peng, C. (2024) · Research · doi:10.34133/research.0351 · Cited by 57 · see citing works

Impaired TCA cycle flux in mitochondria in skeletal muscle from type 2 diabetic subjects: Marker or maker of the diabetic phenotype?

Gaster, M., Nehlin, J. O., & Minet, A. D. (2012) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.656653 · Cited by 53 · see citing works

The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma

Wang, J., Zhang, P., Zhong, J., Tan, M., Ge, J., Tao, L., Li, Y., Zhu, Y., Wu, L., Qiu, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8382 · Cited by 52 · see citing works

Polyvinylpyrrolidone-curcumin nanoparticles with immune regulatory and metabolism regulatory effects for the treatment of experimental autoimmune uveitis

Cao, F., Liang, K., Tang, W., Ni, Q.-Y., Ji, Z., Zha, C.-K., Wang, Y., Jiang, Z., Hou, S., Tao, L., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.047 · Cited by 52 · see citing works

Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC

Yamasaki, T., Tran, T. A. T., Öz, O. K., Raj, G. V., Schwarz, R. E., DeBerardinis, R. J., Zhang, X., & Brugarolas, J. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2010.234 · Cited by 52 · see citing works

Reduced Expression of Fumarate Hydratase in Clear Cell Renal Cancer Mediates HIF-2α Accumulation and Promotes Migration and Invasion

Sudarshan, S., Shanmugasundaram, K., Naylor, S. L., Lin, S., Livi, C. B., O’Neill, C. F., Parekh, D. J., Yeh, I., Sun, L., & Block, K. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021037 · Cited by 52 · see citing works

Targeted therapeutic strategies for the management of renal cell carcinoma

Singer, E. A., Gupta, G. N., & Srinivasan, R. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328351c646 · Cited by 51 · see citing works

Loss of SETD2 Induces a Metabolic Switch in Renal Cell Carcinoma Cell Lines toward Enhanced Oxidative Phosphorylation

Liu, J., Hanavan, P. D., Kras, K. A., Ruiz, Y. W., Castle, E. P., Lake, D. F., Chen, X., O’Brien, D. R., Luo, H., Robertson, K. D., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00628 · Cited by 48 · see citing works

Progress of stimulus responsive nanosystems for targeting treatment of bacterial infectious diseases

Yang, N., Sun, M., Wang, H., Hu, D., Zhang, A., Khan, S., Chen, Z., Chen, D., & Xie, S. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103078 · Cited by 46 · see citing works

Leiomyoma Cutis: A Focused Review on Presentation, Management, and Association with Malignancy

Malik, K., Patel, P. S., Chen, J., & Khachemoune, A. (2015) · American Journal of Clinical Dermatology · doi:10.1007/s40257-015-0112-1 · Cited by 45 · see citing works

PI3K regulation of the SKP-2/p27 axis through mTORC2

Shanmugasundaram, K., Block, K. L., Nayak, B. K., Livi, C. B., Venkatachalam, M. A., & Sudarshan, S. (2012) · Oncogene · doi:10.1038/onc.2012.226 · Cited by 44 · see citing works

The NADPH Oxidase Subunit p22 Inhibits the Function of the Tumor Suppressor Protein Tuberin

Block, K. L., Gorin, Y. C., New, D. D., Eid, A. A., Chełmicki, T., Reed, A. B., Choudhury, G. G., Parekh, D. J., & Abboud, H. E. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090606 · Cited by 43 · see citing works

Adult Renal Cell Carcinoma

Hirsch, M. S., Signoretti, S., & Cin, P. D. (2015) · Surgical pathology clinics · doi:10.1016/j.path.2015.09.003 · Cited by 43 · see citing works

Fumarate Hydratase Deficiency and Cancer: Activation of Hypoxia Signaling?

Ratcliffe, P. J. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.015 · Cited by 50 · see citing works

HIF and fumarate hydratase in renal cancer

Sudarshan, S., Linehan, W. M., & Neckers, L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603547 · Cited by 70 · see citing works

Reduced Expression of Fumarate Hydratase in Clear Cell Renal Cancer Mediates HIF-2α Accumulation and Promotes Migration and Invasion

Sudarshan, S., Shanmugasundaram, K., Naylor, S. L., Lin, S., Livi, C. B., O’Neill, C. F., Parekh, D. J., Yeh, I., Sun, L., & Block, K. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021037 · Cited by 52 · see citing works

Neckers L: HIF and fumarate hydratase in renal cancer

Sudarshan, S., Wm, L., & Neckers, L. (2013)

HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability

Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958 · see citing works